Zitat:"...BETHESDA, Maryland, Feb. 23, 2017 /PRNewswire/ -- The management of Cannabics Pharmaceuticals Inc. (CNBX) wishes to inform its shareholders and public at large that is acutely aware of the significant increase in its share volume this past month and was contacted by OTC Markets on February 21st regarding this matter........Itamar Borochov, CEO of Cannabics Pharmaceuticals, says "We are very aware of the increased interest in our science and its apparent results in the marketplace." I wish to reiterate that there is neither any undisclosed material information available nor any paid promotional activity or Investor Relations for the Company at all. The sole source of the Company's public information has been press releases which we, the Company, authorize and release ourselves and may be found under "News" on OTC Markets site or on our Website (www.Cannabics.com).....
The company believes that its planned commercialization of its Liquid Biopsy Diagnostic tests as announced in our Press Release of February 6th, 2017, contributed to the recent increased activity. .... " ENDE Zitat
Source:www.otcmarkets.com/stock/CNBX/news/...-in-its-Shares?id=151855
Zurück
Weiter
Werbung
